The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

25 Aug 2020 07:00

RNS Number : 0176X
Catenae Innovation PLC
25 August 2020
 

 

 25 August 2020

 

Catenae Innovation PLC

 

("Catenae", the "Company" or the "Group")

 

Business Update

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology provides the following business update.

 

Company Technology IP Development

 

Further to the announcement of 1 July 2020 regarding completion of the Cov-ID app and subsequent announcement on 3 July 2020 regarding completion of the Onsite ID app, the Company is pleased to provide the following product update.

 

In order to provide a more comprehensive product offering to cater for the needs of multiple sectors, Catenae has focused on upgrading its Onsite ID app to deliver an enhanced version of the Cov-ID app. Onsite ID allows multiple health and other work-related documents to be filed in a multi-document digital wallet and passport, and can therefore be used across a range of sectors including healthcare, construction and hospitality.

 

The Company now includes Data Dashboarding as part of the service that it offers its clients. The presentation of data sets within an easy-to-use, instant access dashboard on mobile devices gives business managers the ability to see the health and availability to work status of their workforces and to make fast business decisions ensuring efficient and productive workflows are maintained in the face of Covid-19.

 

Newcastle Premier Health Covid-19 Screening Programme

 

The Company announces the first commercial use of its Onsite ID app in partnership with its occupational health and wellness partner, Newcastle Premier Health Limited ("NPH").

 

NPH has completed the initial screening phase of its Access Control Programme for its customers. Onsite ID performs an integral part of the overall programme that helps businesses get employees back to work safely. Individual Covid-19 test results are set to be entered into the Onsite ID app which then will be used as a digital passport, enabling the users to share their Covid-19 status in a secure, immutable and GDPR compliant manner when meeting clients in person.

 

NPH's Access Control Programme is currently in progress and is expected to complete in the next three weeks. This will provide the Company with a useful case study for further sales and marketing activities.

 

Guy Meyer, Chief Executive Officer of Catenae, said: "We are pleased to have secured our first commercial sale for the Onsite ID app which has just undergone a version upgrade. This sale is testament to the app's effectiveness in managing workforces and providing safety in controlled environments, given its multi-purpose functionality. Our human-focused technologies are designed to mitigate risks for businesses, their people and their customers and I am pleased to see our latest product performing well in these challenging times.

 

"We remain focused on delivering results through building the Company's IP and talent capacity across the business as we further explore international and local sales opportunities, including those with NPH. We look forward to keeping the market updated with our progress."

 

Mark Philpott, Managing Director of NPH, commented: "NPH Group is now working with two new companies in the North East in the Finance and Manufacturing sectors to help them return their staff to work in a safe and supported way.

 

"Combined with Catenae's products, NPH's clinical solutions provide our clients with the ability to test, track and trace employees. Clients will also have the option to monitor the profile of a work population using dashboarding, making it easy for businesses to dynamically manage the risk profile and cycle of Covid-19 incidences, infection and testing. 

 

"We are excited to be at the forefront of providing solutions to businesses, helping them to move forward with confidence."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Chief Executive Officer of the Company.

 

- Ends -

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Chief Executive Officer

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner

Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

Yellow Jersey PR (PR & IP)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins

 

Notes to Editors:

 

About Catenae Innovation PLC

 

Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.

 

www.catenaeinnovation.com

 

Forward-Looking Statements

 

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

 

 

 

The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFFATDISFII
Date   Source Headline
30th Mar 20213:42 pmRNSDirector dealings
30th Mar 20217:00 amRNSUK Government 'COVID-Status Certification Review'
29th Mar 20217:00 amRNSAnnual Report and Accounts, Trading Update
16th Mar 20211:19 pmRNSExercise of Warrant
16th Mar 20219:05 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:13 pmRNSHolding(s) in Company
26th Feb 202111:00 amRNSCorrection re Placing, Conversions, Warrants
22nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20217:00 amRNSDigital Identity Policy Consultation
29th Jan 20217:00 amRNSPilot Agreement
27th Jan 20217:00 amRNSPlacing, Conversions, Warrants & Business Update
11th Jan 20212:06 pmRNSSecond Price Monitoring Extn
11th Jan 20212:01 pmRNSPrice Monitoring Extension
18th Dec 202011:39 amRNSHolding(s) in Company
15th Dec 20203:41 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBusiness Update
9th Dec 20209:27 amRNSHolding(s) in Company
5th Nov 202012:30 pmRNSUpdate on Afrik-ID
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
2nd Nov 202011:06 amRNSSecond Price Monitoring Extn
2nd Nov 202011:00 amRNSPrice Monitoring Extension
16th Oct 20208:43 amRNSIssue of Warrants
16th Oct 20207:00 amRNSJoint Venture with Blackhive Africa Medical
25th Sep 202012:26 pmRNSResult of AGM
4th Sep 202012:50 pmRNSPosting of Notice of AGM
27th Aug 20204:41 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
25th Aug 20207:00 amRNSBusiness Update
24th Aug 20207:00 amRNSCreditor Share Conversion and Notice of AGM
19th Aug 20202:32 pmRNSHolding(s) in Company
23rd Jul 202011:05 amRNSSecond Price Monitoring Extn
23rd Jul 202011:00 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSChange of Director Role and Grant of Options
17th Jul 20207:00 amRNSTransfer and Exercise of Warrants
9th Jul 202011:05 amRNSSecond Price Monitoring Extn
9th Jul 202011:00 amRNSPrice Monitoring Extension
8th Jul 20209:14 amRNSHolding(s) in Company
6th Jul 20202:06 pmRNSSecond Price Monitoring Extn
6th Jul 20202:00 pmRNSPrice Monitoring Extension
6th Jul 20201:15 pmRNSExercise of Warrants
6th Jul 20207:00 amRNSHolding(s) in Company
3rd Jul 20207:30 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSCompletion of New Product - Onsite ID
3rd Jul 20207:00 amRNSCommercial Pilot Agreement with Afrik-ID
2nd Jul 20208:01 amRNSHolding(s) in Company
1st Jul 20203:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.